T Taran
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 13
- Oncology 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
- Lung Cancer Research Studies 2
- Co-authors
- Patrick Neven (4 shared papers)José Baselga (4 shared papers)Michael Gnant (5 shared papers)Kathleen I. Pritchard (2 shared papers)Shinzaburo Noguchi (3 shared papers)Alejandra Perez (2 shared papers)Wentao Feng (2 shared papers)Howard A. Burris (2 shared papers)
- Journals
- Annals of Oncology (6 papers)Cancer Research (6 papers)Geburtshilfe und Frauenheilkunde (1 paper)
- Partner nations
- United StatesBelgiumSwitzerland
In The Last Decade
T Taran
11 papers receiving 724 citations
T Taran's Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 505
- Pulmonary and Respiratory Medicine 561
- Cancer Research 248
- Genetics 113
- Molecular Biology 233
Countries citing papers authored by T Taran
This map shows the geographic impact of T Taran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Taran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Taran more than expected).
Fields of papers citing papers by T Taran
This network shows the impact of papers produced by T Taran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Taran. The network helps show where T Taran may publish in the future.
Co-authors
The 25 scholars most cited alongside T Taran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 Hit paper breakdown → | 2014 | 407 |
| 2 | Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Hit paper breakdown → | 2021 | 161 |
| 3 | 2014 | 93 | |
| 4 | 2023 | 43 | |
| 5 | 2012 | 15 | |
| 6 | 2018 | 10 | |
| 7 | 2024 | 5 | |
| 8 | 2013 | 2 | |
| 9 | 2016 | 2 | |
| 10 | 2012 | 1 | |
| 11 | 2013 | 1 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 1 |
About T Taran
T Taran is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Genetics and Epidemiology, having authored 13 papers that have together received 742 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (13 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Estrogen and related hormone effects (3 papers), Cancer-related Molecular Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Lung Cancer Research Studies (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (505 citations), Pulmonary and Respiratory Medicine (561 citations), Cancer Research (248 citations), Genetics (113 citations) and Molecular Biology (233 citations). T Taran has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include Patrick Neven, José Baselga, Michael Gnant, Kathleen I. Pritchard, Shinzaburo Noguchi, Alejandra Perez, Wentao Feng, Howard A. Burris, Hope S. Rugo and Martine Piccart. Their work appears in journals such as Annals of Oncology, Cancer Research and Geburtshilfe und Frauenheilkunde.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.